Abstract: The present invention relates to fungal cells, in particular methylotrophic fungal cells, for use in improved production of recombinant peptides of interest and processes for producing recombinant peptides of interest.

Abstract: The present invention relates to a method for increasing the efficiency of a solar module or a solar collector, wherein the solar module or the solar collector comprises a glass pane on the side that faces toward the sun. The method comprises the steps of applying an aqueous solution of collagen hydrolysate to the glass pane and allowing the aqueous solution to dry.

Abstract: A sole structure for an article of footwear includes a first conical traction element disposed in a forefoot region of the sole structure. The sole structure also includes a first elongate traction element, a second elongate traction element, and a third elongate traction element arranged in a radial pattern around the first conical traction element within the forefoot region.

Abstract: The present invention relates to collagen hydrolysate for use as an active substance in the treatment of inflammatory skin disorders and intestinal disorders and/or skin disorders and intestinal disorders accompanied by inflammation.

Abstract: The present invention relates to a method for producing collagen peptide preparations comprising recombinant collagen peptides, to collagen peptide preparations produced by means of said methods, to products containing the collagen peptide preparations and to uses of the aforementioned preparations and products.

Abstract: Articles of footwear having an upper that includes a tensile support structure are described. The tensile support structure is formed by a plurality of strands that are arranged in a chain-linked configuration. The chain-linked arrangement of the strands assists with distributing tensile forces over portions of the upper of the article of footwear and helps to conforms the upper to a foot of a wearer upon the application of tension.

Abstract: Aspects herein are directed to a knitted upper and articles of footwear that incorporate the same that include raised elements that extend in a z-direction away from an outer surface of the knitted upper. The raised elements comprise a thermoformed network of interlooped yarns. A first set of raised elements extends in a first direction on a lateral side of the knitted upper, and a second set of raised elements extends in a second direction on a medial side of the knitted upper where the second direction is different from the first direction.

Abstract: An article of footwear with a heel region including a posterior end of the article of footwear, a mid-foot region, and a forefoot region including an anterior end of the article of footwear; a lateral side, and a medial side opposite the lateral side; an upper; and a sole structure coupled to the upper. The sole structure has a midsole with a first cushioning element extending from the posterior end to the anterior end; a second cushioning element extending from the mid-foot region to the posterior end, the second cushioning element being formed of a different material than the first cushioning element; and a shell with a plurality of circumferentially-spaced apart protrusions, wherein each of the plurality of protrusions is directly coupled to the second cushioning element.

Abstract: The present invention relates to the use of collagen hydrolysate for improving endurance performance by increasing mitochondrial activity. Further, the invention relates to the use of collagen hydrolysate for stimulating lipid catabolism, and in particular for reducing body weight, by increasing mitochondrial activity.

Abstract: The present invention relates to recombinant, in particular non-denatured, type II collagen for use in a therapeutic method for oral therapy of cartilage disease of a human or animal patient.

Abstract: The present invention relates to a nutritionally optimized synthetic or recombinant collagen peptide comprising at least one amino acid sequence motif (glycine-X-Y)n, and the collagen peptide according to the invention for use in a method for therapeutic treatment of the human or animal body and products containing the collagen peptide according to the invention.

Abstract: An article of footwear with a heel region including a posterior end of the article of footwear, a mid-foot region, and a forefoot region including an anterior end of the article of footwear; a lateral side, and a medial side opposite the lateral side; an upper; and a sole structure coupled to the upper. The sole structure has a midsole with a first cushioning element extending from the posterior end to the anterior end; a second cushioning element extending from the mid-foot region to the posterior end, the second cushioning element being formed of a different material than the first cushioning element; and a shell with a plurality of circumferentially-spaced apart protrusions, wherein each of the plurality of protrusions is directly coupled to the second cushioning element.

Abstract: The present invention relates to collagen hydrolysate for use as an active substance in order to delay the ageing of cells in the bodies of humans or animals.

Abstract: A sole structure for an article of footwear includes a bladder and at least one insert. The bladder includes an upper surface having a first portion defining a chamber and a second portion defining at least one recess adjacent to the chamber. The at least one insert is disposed within the at least one recess and has a top surface that is substantially flush with the first portion of the upper surface of the bladder. The first portion of the upper surface is exposed to the at least one insert.

Abstract: The present invention relates to a method for producing collagen peptide preparations comprising recombinant collagen peptides, to collagen peptide preparations produced by means of said methods, to products containing the collagen peptide preparations and to uses of the aforementioned preparations and products.

Abstract: The following invention relates to collagen hydrolysate for use as an active substance in the treatment and/or prophylaxis of periodontitis or gingivitis.

Abstract: The present invention relates to the use of collagen hydrolysate for improving endurance performance by increasing mitochondrial activity. Further, the invention relates to the use of collagen hydrolysate for stimulating lipid catabolism, and in particular for reducing body weight, by increasing mitochondrial activity.

Abstract: The present invention relates to a synthetically or recombinantly produced collagen peptide for use in a method for the therapeutic treatment of the human or animal body having a molecular weight in a range from 0.18 to 10.0 kDa, in particular 0.18 to 5.0 kDa, in particular 1.1 to 5.0 kDa, products which comprise a collagen peptide according to the invention, and a method for producing a collagen peptide according to the invention.

Abstract: The present invention relates to the use of collagen hydrolysate for improving endurance performance by increasing mitochondrial activity. Further, the invention relates to the use of collagen hydrolysate for stimulating lipid catabolism, and in particular for reducing body weight, by increasing mitochondrial activity.

Abstract: The present invention relates to collagen hydrolysate for use as an active substance in the treatment of inflammatory skin disorders and intestinal disorders and/or skin disorders and intestinal disorders accompanied by inflammation.